Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies - PubMed (original) (raw)
. 2000 May;57(5):1000-10.
Affiliations
- PMID: 10779385
Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies
P L Prather et al. Mol Pharmacol. 2000 May.
Abstract
Previous studies had shown that the amplification factors for cannabinoid receptors, defined as the number of total G proteins activated per occupied receptor, differs between several rat brain regions. In this study, we sought to determine which specific Gi/Go(alpha) subunits were activated by CB1 receptors in several rat brain regions and if this coupling might explain the regional differences in receptor/G protein amplification factors. Furthermore, we examined whether cannabinoid agonists might activate different subtypes of G(alpha) subunits with varying degrees of efficacy and/or potency. Activation of specific G proteins by cannabinoid receptors was evaluated by the ability of the agonist WIN 55212-2 to stimulate incorporation of [alpha-(32)P]azidoanilido-GTP into G(alpha) subunits in membranes. Photolabeled G proteins were either directly resolved using urea/SDS-polyacrylamide gel electrophoresis or first immunoprecipitated with specific antisera for different G(alpha) subunits before electrophoresis. Individual G(alpha) subunits were separated into distinct bands on a single gel and the amount of agonist-induced increase in radioactivity was quantified by densitometry. Stimulation of CB1 receptors by WIN 55212-2 resulted in the activation of a distinct pattern of at least five different G(ialpha)/G(oalpha) subunits in several brain regions. Furthermore, although the pattern of G proteins activated by WIN 55212-2 appeared to be similar across brain regions, slight differences were observed in both the percentage of increase and the amount of the individual G(alpha) subunits activated. Most importantly, the amount of WIN 55212-2 required to half-maximally activate individual G proteins in the cerebellum varied over a 30-fold range for different G(alpha) subunits. These results suggest that cannabinoid receptors activate multiple G proteins simultaneously in several brain regions and both the efficacy and potency of cannabinoid agonists to activate individual G(alpha) subunits may vary considerably.
Similar articles
- Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
Breivogel CS, Sim LJ, Childers SR. Breivogel CS, et al. J Pharmacol Exp Ther. 1997 Sep;282(3):1632-42. J Pharmacol Exp Ther. 1997. PMID: 9316881 - Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Selley DE, Stark S, Sim LJ, Childers SR. Selley DE, et al. Life Sci. 1996;59(8):659-68. doi: 10.1016/0024-3205(96)00347-5. Life Sci. 1996. PMID: 8761016 - Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C. Sagan S, et al. Eur J Neurosci. 1999 Feb;11(2):691-9. doi: 10.1046/j.1460-9568.1999.00480.x. Eur J Neurosci. 1999. PMID: 10051770 - Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells.
Ho BY, Stadnicka A, Prather PL, Buckley AR, Current LL, Bosnjak ZJ, Kwok WM. Ho BY, et al. Endocrinology. 2000 May;141(5):1675-85. doi: 10.1210/endo.141.5.7454. Endocrinology. 2000. PMID: 10803576 - Activation of G-proteins in brain by endogenous and exogenous cannabinoids.
Childers SR. Childers SR. AAPS J. 2006 Mar 10;8(1):E112-7. doi: 10.1208/aapsj080113. AAPS J. 2006. PMID: 16584117 Free PMC article. Review.
Cited by
- New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.
Kenakin T. Kenakin T. Br J Pharmacol. 2013 Feb;168(3):554-75. doi: 10.1111/j.1476-5381.2012.02223.x. Br J Pharmacol. 2013. PMID: 22994528 Free PMC article. Review. - Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT, Hudson B, Yegorova S, Jollimore CA, Kelly ME. McIntosh BT, et al. Br J Pharmacol. 2007 Dec;152(7):1111-20. doi: 10.1038/sj.bjp.0707495. Epub 2007 Oct 8. Br J Pharmacol. 2007. PMID: 17922024 Free PMC article. - Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC.
Hutchison RD, Ford BM, Franks LN, Wilson CD, Yarbrough AL, Fujiwara R, Su MK, Fernandez D, James LP, Moran JH, Patton AL, Fantegrossi WE, Radominska-Pandya A, Prather PL. Hutchison RD, et al. Front Pharmacol. 2018 Sep 26;9:1084. doi: 10.3389/fphar.2018.01084. eCollection 2018. Front Pharmacol. 2018. PMID: 30319418 Free PMC article. - Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.
Bosier B, Hermans E, Lambert D. Bosier B, et al. Br J Pharmacol. 2008 Sep;155(1):24-33. doi: 10.1038/bjp.2008.230. Epub 2008 Jun 9. Br J Pharmacol. 2008. PMID: 18536748 Free PMC article. - A simple method for quantifying functional selectivity and agonist bias.
Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, Novick S. Kenakin T, et al. ACS Chem Neurosci. 2012 Mar 21;3(3):193-203. doi: 10.1021/cn200111m. Epub 2011 Dec 20. ACS Chem Neurosci. 2012. PMID: 22860188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous